8-K
PRO-PHARMACEUTICALS 8-K
- Company
- GALECTIN THERAPEUTICS INC
- Filed
- March 23, 2005
- Period of Report
- March 22, 2005
- Accession Number
- 0001157523-05-002772
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →